140 related articles for article (PubMed ID: 35496614)
1. Design, synthesis and biological evaluation of novel amide-linked 18β-glycyrrhetinic acid derivatives as novel ALK inhibitors.
Cai D; Zhang ZH; Chen Y; Ruan C; Li SQ; Chen SQ; Chen LS
RSC Adv; 2020 Mar; 10(20):11694-11706. PubMed ID: 35496614
[TBL] [Abstract][Full Text] [Related]
2. Exploring New Structural Features of the 18β-Glycyrrhetinic Acid Scaffold for the Inhibition of Anaplastic Lymphoma Kinase.
Cai D; Zhang Z; Chen Y; Zhang Y; Sun Y; Gong Y
Molecules; 2019 Oct; 24(19):. PubMed ID: 31597403
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Antiviral and Antitumor Activities of Novel 18
Pan BW; Zheng LL; Shi Y; Dong ZC; Feng TT; Yang J; Wei Y; Zhou Y
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834459
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1.
Wang Y; Zhang G; Hu G; Bu Y; Lei H; Zuo D; Han M; Zhai X; Gong P
Eur J Med Chem; 2016 Nov; 123():80-89. PubMed ID: 27474925
[TBL] [Abstract][Full Text] [Related]
7. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
8. Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation.
Khan SN; Shaheen F; Aleem U; Sheikh S; Tamfu AN; Ashraf S; Ul-Haq Z; Ullah S; Wahab AT; Choudhary MI; Jahan H
Eur J Pharm Sci; 2022 Jan; 168():106045. PubMed ID: 34666184
[TBL] [Abstract][Full Text] [Related]
9. Derivatization, molecular docking and
Abdel Bar FM; Elimam DM; Mira AS; El-Senduny FF; Badria FA
Nat Prod Res; 2019 Sep; 33(18):2591-2599. PubMed ID: 29656653
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Biological Evaluation of Glycyrrhetic Acid Derivatives as Potential VEGFR2 Inhibitors.
Yan TL; Bai LF; Zhu HL; Zhang WM; Lv PC
ChemMedChem; 2017 Jul; 12(13):1087-1096. PubMed ID: 28599090
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
Jin L; Huang R; Huang X; Zhang B; Ji M; Wang H
Bioorg Med Chem; 2018 May; 26(8):1759-1775. PubMed ID: 29486954
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.
El-Adl K; El-Helby AA; Sakr H; Eissa IH; El-Hddad SSA; M I A Shoman F
Bioorg Chem; 2020 Sep; 102():104059. PubMed ID: 32653608
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of dehydroabietic acid-pyrimidine hybrids as antitumor agents.
Huang L; Huang R; Pang F; Li A; Huang G; Zhou X; Li Q; Li F; Ma X
RSC Adv; 2020 May; 10(31):18008-18015. PubMed ID: 35517208
[TBL] [Abstract][Full Text] [Related]
15. [Design, synthesis and antiproliferative activity in cancer cells of novel 18β-glycyrrhetinic acid derivatives].
Huang M; Li K; Jin SY; Cui TX; Liu D; Zhao LX
Yao Xue Xue Bao; 2015 Oct; 50(10):1263-71. PubMed ID: 26837172
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
Zou LW; Li YG; Wang P; Zhou K; Hou J; Jin Q; Hao DC; Ge GB; Yang L
Eur J Med Chem; 2016 Apr; 112():280-288. PubMed ID: 26900660
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors.
Liu S; Jiang Y; Yan R; Li Z; Wan S; Zhang T; Wu X; Hou J; Zhu Z; Tian Y; Zhang J
Eur J Med Chem; 2019 Oct; 179():358-375. PubMed ID: 31260890
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 18β-glycyrrhetinic piperazine amides displaying significant in vitro and in vivo antibacterial activities against intractable plant bacterial diseases.
Xiang M; Song YL; Ji J; Zhou X; Liu LW; Wang PY; Wu ZB; Li Z; Yang S
Pest Manag Sci; 2020 Sep; 76(9):2959-2971. PubMed ID: 32246577
[TBL] [Abstract][Full Text] [Related]
20. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
